{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:16:18Z","timestamp":1774685778381,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ecl.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T15:47:46Z","timestamp":1636559266000},"page":"609-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sporadic Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"50","author":[{"given":"Stephanie J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores M.","family":"Shoback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2021.07.006_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/BOR.0000000000000511","article-title":"Primary hyperparathyroidism: recent advances","volume":"30","author":"Walker","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ecl.2021.07.006_bib3","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00268-007-9427-2","article-title":"Age- and sex-related incidence of surgically treated primary hyperparathyroidism","volume":"32","author":"Miller","year":"2008","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.ecl.2021.07.006_bib7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism","volume":"16","author":"Silverberg","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.ecl.2021.07.006_bib9","doi-asserted-by":"crossref","first-page":"921814","DOI":"10.1155\/2011\/921814","article-title":"Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends","volume":"2011","author":"Pradeep","year":"2011","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib10","first-page":"158","article-title":"Primary hyperparathyroidism in women: a tale of two cities--New York and Beijing","volume":"45","author":"Bilezikian","year":"2000","journal-title":"Int J Fertil Womens Med"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4248\/BR201302005","article-title":"Primary hyperparathyroidism: a tale of two cities revisited \u2014 New York and Shanghai","volume":"1","author":"Liu","year":"2013","journal-title":"Bone Res"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2021.07.006_bib12","first-page":"N30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib13","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","article-title":"Parathyroid tumors and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib14","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1530\/EC-17-0283","article-title":"Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks","volume":"7","author":"Mizamtsidi","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib15","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endo Rel Canc"},{"issue":"21","key":"10.1016\/j.ecl.2021.07.006_bib16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib17","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J\u00a0Bone Min Res"},{"issue":"7","key":"10.1016\/j.ecl.2021.07.006_bib18","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/0004-2730000003381","article-title":"Bone disease in primary hyperparathyroidism","volume":"58","author":"Bandeira","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib20","first-page":"723","article-title":"Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(99)00150-7","article-title":"Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2021.07.006_bib22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Ejlsmark-Svensson","year":"2021","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.ecl.2021.07.006_bib24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control Study","volume":"33","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ecl.2021.07.006_bib25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7414","key":"10.1016\/j.ecl.2021.07.006_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism","volume":"327","author":"Vestergaard","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ecl.2021.07.006_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archsurg.141.9.885","article-title":"The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism","volume":"141","author":"VanderWalde","year":"2006","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.ecl.2021.07.006_bib28","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/2230-8210.93745","article-title":"Renal manifestations of primary hyperparathyroidism","volume":"16","author":"Lila","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib30","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1210\/jc.2013-4192","article-title":"Predictors of renal function in primary hyperparathyroidism","volume":"99","author":"Walker","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ecl.2021.07.006_bib31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A\u00a010-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ecl.2021.07.006_bib32","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jocd.2012.11.008","article-title":"Non-traditional manifestations of primary hyperparathyroidism","volume":"16","author":"Walker","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"36","key":"10.1016\/j.ecl.2021.07.006_bib35","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3748\/wjg.v17.i36.4063","article-title":"Digestive manifestations of parathyroid disorders","volume":"17","author":"Abboud","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-199509000-00017","article-title":"Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study","volume":"222","author":"Chan","year":"1995","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic Primary Hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib40","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00268-016-3514-1","article-title":"Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"40","author":"Singh Ospina","year":"2016","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mric.2017.08.009","article-title":"Update in parathyroid imaging","volume":"26","author":"Kuzminski","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"6","key":"10.1016\/j.ecl.2021.07.006_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12672-018-0347-4","article-title":"Diagnostic performance of F-18 Fluorocholine PET\/CT for parathyroid localization in hyperparathyroidism: a systematic review and meta-analysis","volume":"9","author":"Kim","year":"2018","journal-title":"Horm Canc"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3348\/kjr.2019.0268","article-title":"Performance of F-18 Fluorocholine PET\/CT for detection of hyperfunctioning parathyroid tissue in patients with elevated parathyroid hormone levels and negative or discrepant results in conventional imaging","volume":"21","author":"Uslu-Be\u015fli","year":"2020","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1148\/radiol.2016160768","article-title":"18F Fluorocholine PET\/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study","volume":"284","author":"Kluijfhout","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A\u00a0systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ecl.2021.07.006_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jss.2019.08.007","article-title":"Persistent\/recurrent primary hyperparathyroidism: does the number of abnormal glands play a role?","volume":"246","author":"Mazotas","year":"2020","journal-title":"J\u00a0Surg Res"},{"issue":"9","key":"10.1016\/j.ecl.2021.07.006_bib47","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib48","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib49","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2021.07.006_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","article-title":"The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake","volume":"41","author":"Jorde","year":"2002","journal-title":"Eur J Nutr"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2021.07.006_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.beem.2018.09.006","article-title":"Non-surgical management of primary hyperparathyroidism","volume":"32","author":"Cetani","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib54","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ecl.2021.07.006_bib56","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study","volume":"87","author":"Parker","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.07.006_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2021.07.006_bib58","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib59","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.ecl.2021.07.006_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/415719","article-title":"Cinacalcet treatment of primary hyperparathyroidism","volume":"2011","author":"Rothe","year":"2011","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2021.07.006_bib62","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1530\/EC-20-0221","article-title":"Cinacalcet and primary hyperparathyroidism: systematic review and meta regression","volume":"9","author":"Ng","year":"2020","journal-title":"Endocr Connect"},{"issue":"8","key":"10.1016\/j.ecl.2021.07.006_bib63","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2021.07.006_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2021.07.006_bib65","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5603\/EP.2017.0023","article-title":"Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery","volume":"68","author":"Misiorowski","year":"2017","journal-title":"Endokrynol Pol"},{"issue":"3","key":"10.1016\/j.ecl.2021.07.006_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.ecl.2021.07.006_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:46:47Z","timestamp":1760176007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889852921000694"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.07.006","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sporadic Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}